Critics of the bill suggested that it would allow patents on pathogen genetic material, which could hamper the ability to test and treat in future pandemics.
US Senate Hearings Consider Bipartisan Proposal to Change Patent Laws; Could Have Big Impact on Dx
A draft bill provides for a major expansion of eligible material, a move the ACLU and AMP said threatens to reduce competition in genetic testing.
Experts Debate MDx Industry Impact of AMP v. Myriad Three Years After Court's Decision
The US Supreme Court decision cleared the way for large-scale sequencing or drove prices to unsustainable levels, depending on your opinion.
Patients File HIPAA Complaint Against Myriad Genetics for Withholding Variant Data
Four patients still want the government to investigate their allegations against Myriad, even though the firm complied with their data request at the last hour.
US Supreme Court Hears Arguments For, Against Gene Patents
WASHINGTON (GenomeWeb News) – US Supreme Court justices today heard arguments in favor of and against the patent eligibility of genes isolated from the body, a practice that the US Patent and Trademark Office has enabled for more than three decades.
Oct 13, 2011
Sep 7, 2011
Apr 5, 2011
Myriad, ACLU Case Hits Higher Court
Jun 30, 2010
Jun 23, 2010
Jun 16, 2010